Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi

scientific article

Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CID/CIR413
P932PMC publication ID3202326
P698PubMed publication ID21810754
P5875ResearchGate publication ID51541744

P50authorLynne MofensonQ43882680
Newton KumwendaQ45453026
Taha E. TahaQ55523359
P2093author name stringDonald R Hoover
Shu Chen
Allan Taylor
Michael C Thigpen
Mary Glenn Fowler
Kondwani Nkanaunena
Linda Mipando
P2860cites workElevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothersQ33587760
Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, UgandaQ33926411
Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in ZambiaQ34108680
Antiretroviral regimens in pregnancy and breast-feeding in BotswanaQ34395082
Hospitalization and mortality among primarily nonbreastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006.Q35006316
Maternal or infant antiretroviral drugs to reduce HIV-1 transmissionQ36231035
Effects of early, abrupt weaning on HIV-free survival of children in ZambiaQ36960424
Breastfeeding to prevent HIV transmission in infants: balancing pros and consQ37056104
Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in ZambiaQ37258413
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi StudyQ38404645
The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian childrenQ38462880
Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural UgandaQ38873708
Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family membersQ38880788
Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.Q40627787
Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in MalawiQ43257966
Effect of early exclusive breastfeeding on morbidity among infants born to HIV-negative mothers in ZimbabweQ44850980
Balancing maternal and infant benefits and the consequences of breast-feeding in the developing world during the era of HIV infectionQ46340412
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmissionQ46558677
Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.Q46564603
Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysisQ56092169
The Effect of Human Immunodeficiency Virus and Breastfeeding on the Nutritional Status of African ChildrenQ57207520
Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant MortalityQ73858301
The risks of not breastfeedingQ84626039
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectMalawiQ1020
breastfeedingQ174876
P304page(s)388-395
P577publication date2011-08-01
P1433published inClinical Infectious DiseasesQ5133764
P1476titleEffects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi
P478volume53

Reverse relations

cites work (P2860)
Q47546162Adherence to WHO breastfeeding guidelines among HIV positive mothers in Southern Ethiopia: implication for intervention
Q39234019Advances in therapy for the prevention of HIV transmission from mother to child
Q47258824Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies
Q34350135Early cessation of breastfeeding amongst women in South Africa: an area needing urgent attention to improve child health
Q91214793Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial
Q35804683Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial
Q35815018Efficacy of WHO recommendation for continued breastfeeding and maternal cART for prevention of perinatal and postnatal HIV transmission in Zambia
Q31116941Factors associated with coverage of cotrimoxazole prophylaxis in HIV-exposed children in South Africa
Q40358189Formula-Feeding of HIV-Exposed Uninfected African Children Is Associated with Faster Growth in Length during the First 6 Months of Life in the Kesho Bora Study
Q35980844Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration
Q57476292HIV Exposure and Formula Feeding Predict Under-2 Mortality in HIV-Uninfected Children, Botswana
Q37703445HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana
Q36020074HIV-1 concentrations in human breast milk before and after weaning
Q36083089HIV-exposed children account for more than half of 24-month mortality in Botswana
Q30062047HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination.
Q35825690Health outcomes of HIV-exposed uninfected African infants
Q37080573Immunology of pediatric HIV infection
Q35003365Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration
Q45324416Investigating Mediators of the Poor Pneumonia Outcomes of Human Immunodeficiency Virus-Exposed but Uninfected Children.
Q28077904Linking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected Infants
Q36866309Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial
Q28534751Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery
Q55546839Morbidity and mortality in HIV-exposed uninfected children
Q34511322Morbidity in relation to feeding mode in African HIV-exposed, uninfected infants during the first 6 mo of life: the Kesho Bora study
Q26752637Mortality risk and associated factors in HIV-exposed, uninfected children
Q35114754Predictors of breastfeeding cessation among HIV infected mothers in Southern Ethiopia: a survival analysis
Q48569593Prevention of Hiv-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in Hiv-1-Infected Women with High Cd4 Cell Count (Impaact Promise): A R
Q33852927Prevention of mother-to-child transmission of HIV: Postpartum adherence to Option B+ until 18 months in Western Uganda
Q43706747Protecting infants of HIV-positive mothers in Malawi
Q37101067Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol
Q37037065Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN study
Q34169396The role of environmental factors in modulating immune responses in early life
Q36377376Treatment Failures and Excess Mortality Among HIV-Exposed, Uninfected Children With Pneumonia

Search more.